Arbutus Biopharma

News

Moderna's settlement of patent litigation with Arbutus and Genevant over technology used in its Spikevax COVID vaccine could reach up to $2.25bn.

News

Regeneron's LAG-3 inhibitor fianlimab has missed the mark in a highly anticipated melanoma trial, hitting its share price.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.